Why is UIP peripheral?

References

• Salvatore M, Smith ML. Cross sectional imaging of pulmonary fibrosis translating pathology into radiology. Vol. 51. : New York: Clin Imaging; 2018. p. 332–336.
   Google Scholar
• Crystal RG, Fulmer, JD, Roberts, WC, et al. Idiopathic pulmonary fibrosis. clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med. 1976;85(6):769–788.
   PubMed Web of Science ®Google Scholar
• Lin Y, Xu Z. Fibroblast senescence in idiopathic pulmonary fibrosis. Front Cell Dev Biol. 2020;8:593283.
   PubMed Web of Science ®Google Scholar
• Diridollou T, Sohier L, Rousseau C, et al. Idiopathic pulmonary fibrosis: significance of the usual interstitial pneumonia (UIP) CT-scan patterns defined in new international guidelines. Respir Med Res. 2020;77:72–78.
   PubMedGoogle Scholar
• Glassberg MK. Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape. Am J Manag Care. 2019;25(11 Suppl):S195–S203.
   PubMedGoogle Scholar
• Raghu G, Nicholson AG, Lynch D. The classification, natural history and radiological/histological appearance of idiopathic pulmonary fibrosis and the other idiopathic interstitial pneumonias. Eur Respir J. 2008;32(1):17.
   PubMedGoogle Scholar
• Gaikwad AV, Eapen MS, McAlinden KD, et al. Endothelial to mesenchymal transition (EndMT) and vascular remodeling in pulmonary hypertension and idiopathic pulmonary fibrosis. Expert Rev Respir Med. 2020;14(10):1027–1043.
   PubMed Web of Science ®Google Scholar
• Barratt S, Millar A. Vascular remodelling in the pathogenesis of idiopathic pulmonary fibrosis. Qjm. 2014;107(7):515–519.
   PubMed Web of Science ®Google Scholar
• Hartopo AB, Arfian N, Nakayama K, et al. Endothelial-derived endothelin-1 promotes pulmonary vascular remodeling in bleomycin-induced pulmonary fibrosis. Physiol Res. 2018;67(Suppl 1):S185–S197.
   PubMedGoogle Scholar
• Swigris JJ, Brown KK. The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis. BioDrugs. 2010;24(1):49–54.
   PubMed Web of Science ®Google Scholar
• Gaikwad AV, et al. Vascular remodelling in idiopathic pulmonary fibrosis patients and its detrimental effect on lung physiology: potential role of endothelial-to-mesenchymal transition. ERJ Open Res. 2022;8(1 00571–2021).
   PubMedGoogle Scholar
• Ebina M, Shimizukawa M, Shibata N, et al. Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2004;169(11):1203–1208.
   PubMed Web of Science ®Google Scholar
• Palta S, Saroa R, Palta A. Overview of the coagulation system. Indian J Anaesth. 2014;58(5):515–523.
   PubMedGoogle Scholar
• Scotton CJ, Krupiczojc MA, Königshoff M, et al. Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest. 2009;119(9):2550–2563.
   PubMed Web of Science ®Google Scholar
• Crooks MG, Hart SP. Coagulation and anticoagulation in idiopathic pulmonary fibrosis. Eur Respir Rev. 2015;24(137):392–399.
   PubMed Web of Science ®Google Scholar
• Sode BF, Dahl M, Nielsen SF, et al. Venous thromboembolism and risk of idiopathic interstitial pneumonia: a nationwide study. Am J Respir Crit Care Med. 2010;181(10):1085–1092.
   PubMed Web of Science ®Google Scholar
• Lang M, Som A, Mendoza DP, et al. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. Lancet Infect Dis. 2020;20(12):1365–1366.
   PubMed Web of Science ®Google Scholar
• Bonaventura A, Vecchié A, Dagna L, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5):319–329.
   PubMed Web of Science ®Google Scholar
• Nader D, Fletcher N, Curley GF, et al. SARS-CoV-2 uses major endothelial integrin αvβ3 to cause vascular dysregulation in-vitro during COVID-19. PLoS One. 2021;16(6):e0253347.
   PubMed Web of Science ®Google Scholar
• Salvatore MM, Capaccione KM, Saqi A, et al. Characteristic patterns of SARS-CoV-2 on chest CT suggests a hematologic pathway for viral entry into the lung. Clin Imaging. 2022;89:92–94.
   PubMed Web of Science ®Google Scholar
• Jose RJ, Williams AE, Chambers RC. Proteinase-activated receptors in fibroproliferative lung disease. Thorax. 2014;69(2):190–192.
   PubMed Web of Science ®Google Scholar
• Jenkins RG, Xiao, S, Su, G, et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest. 2006;116(6):1606–1614.
   PubMed Web of Science ®Google Scholar
• Puthawala K, Hadjiangelis N, Jacoby SC, et al. Inhibition of integrin alpha(v)beta6, an activator of latent transforming growth factor-beta, prevents radiation-induced lung fibrosis. Am J Respir Crit Care Med. 2008;177(1):82–90.
   PubMed Web of Science ®Google Scholar
• Noth I, Anstrom KJ, Calvert SB, et al. A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2012;186(1):88–95.
   PubMed Web of Science ®Google Scholar
• Shea BS, Probst CK, Brazee PL, et al. Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis. JCI Insight. 2017;2(9). DOI:10.1172/jci.insight.86608.
   PubMed Web of Science ®Google Scholar
• Zhang T, Liu M, Gao Y, et al. Salvianolic acid B inhalation solution enhances antifibrotic and anticoagulant effects in a rat model of pulmonary fibrosis. Biomed Pharmacother. 2021;138:111475.
   PubMed Web of Science ®Google Scholar
• Bai L, Zhang L, Pan T, et al. Idiopathic pulmonary fibrosis and diabetes mellitus: a meta-analysis and systematic review. Respir Res. 2021;22(1):175.
   PubMed Web of Science ®Google Scholar
• Rajasurya V, Gunasekaran K, Surani S. Interstitial lung disease and diabetes. World J Diabetes. 2020;11(8):351–357.
   PubMed Web of Science ®Google Scholar
• Wang D, Ma, Y, Tong, G, et al. Diabetes mellitus contributes to idiopathic pulmonary fibrosis: a review from clinical appearance to possible pathogenesis. Vol. 8. Switzerland: Front Public Health; 2020. p. 196.
   Google Scholar
• Carloni A, Poletti V, Fermo L, et al. Heterogeneous distribution of mechanical stress in human lung: a mathematical approach to evaluate abnormal remodeling in IPF. J Theor Biol. 2013;332:136–140.
   PubMed Web of Science ®Google Scholar
• Marchioni A, Tonelli R, Cerri S, et al. Pulmonary stretch and lung mechanotransduction: implications for progression in the fibrotic lung. Int J Mol Sci. 2021;22(12):6443.
   PubMed Web of Science ®Google Scholar
• Leslie KO. Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis. Arch Pathol Lab Med. 2012;136(6):591–600.
   PubMed Web of Science ®Google Scholar
• Albert RK, Smith B, Perlman CE, et al. Is progression of pulmonary fibrosis due to ventilation-induced lung injury? Am J Respir Crit Care Med. 2019;200(2):140–151.
   PubMed Web of Science ®Google Scholar
• Scharm SC, Schafer-Prokop, C, Wilmann, M, et al. Increased regional ventilation as early imaging marker for future disease progression of interstitial lung disease: a feasibility study. 2022;Eur Radiol (9):6046–6057 .
   Google Scholar
• Huang X, Yang N, Fiore VF, et al. Matrix Stiffness–Induced myofibroblast differentiation is mediated by intrinsic mechanotransduction. Am J Respir Cell Mol Biol. 2012;47(3):340–348.
   PubMed Web of Science ®Google Scholar
• Asano S, Ito S, Takahashi K, et al. Matrix stiffness regulates migration of human lung fibroblasts. Physiol Rep. 2017;5(9):e13281.
   PubMed Web of Science ®Google Scholar
• Hinz B, Phan SH, Thannickal VJ, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol. 2012;180(4):1340–1355.
   PubMed Web of Science ®Google Scholar
• Wipff PJ, Rifkin DB, Meister -J-J, et al. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol. 2007;179(6):1311–1323.
   PubMed Web of Science ®Google Scholar
• Schwartz MA. Integrins and extracellular matrix in mechanotransduction. Cold Spring Harb Perspect Biol. 2010;2(12):a005066.
   PubMed Web of Science ®Google Scholar
• Liu F, Lagares D, Choi KM, et al. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis. Am J Physiol Lung Cell Mol Physiol. 2015;308(4):L344–57.
   PubMed Web of Science ®Google Scholar
• Yang J, Pan X, Wang L, et al. Alveolar cells under mechanical stressed niche: critical contributors to pulmonary fibrosis. Mol Med. 2020;26(1):95.
   PubMed Web of Science ®Google Scholar
• Knudsen L, Ruppert C, Ochs M. Tissue remodelling in pulmonary fibrosis. Cell Tissue Res. 2017;367(3):607–626.
   PubMed Web of Science ®Google Scholar
• Lutz D, Gazdhar A, Lopez-Rodriguez E, et al. Alveolar derecruitment and collapse induration as crucial mechanisms in lung injury and fibrosis. Am J Respir Cell Mol Biol. 2015;52(2):232–243.
   PubMed Web of Science ®Google Scholar
• Bates JHT, Davis GS, Majumdar A, et al. Linking parenchymal disease progression to changes in lung mechanical function by percolation. Am J Respir Crit Care Med. 2007;176(6):617–623.
   PubMed Web of Science ®Google Scholar
• Wu H, Yu Y, Huang H, et al. Progressive pulmonary fibrosis is caused by elevated mechanical tension on alveolar stem cells. Cell. 2021;184(3):845–846.
   PubMed Web of Science ®Google Scholar
• Nureki S-I, Tomer Y, Venosa A, et al. Expression of mutant Sftpc in murine alveolar epithelia drives spontaneous lung fibrosis. J Clin Invest. 2018;128(9):4008–4024.
   PubMed Web of Science ®Google Scholar
• Enomoto N, Suda T, Kono M, et al. Amount of elastic fibers predicts prognosis of idiopathic pulmonary fibrosis. Respir Med. 2013;107(10):1608–1616.
   PubMed Web of Science ®Google Scholar
• von der Thusen JH. Pleuroparenchymal fibroelastosis: its pathological characteristics. Curr Respir Med Rev. 2013;9(4):238–247.
   PubMedGoogle Scholar
• Mariappan YK, Kolipaka A, Manduca A, et al. Magnetic resonance elastography of the lung parenchyma in an in situ porcine model with a noninvasive mechanical driver: correlation of shear stiffness with trans-respiratory system pressures. Magn Reson Med. 2012;67(1):210–217.
   PubMed Web of Science ®Google Scholar
• Raghu G, Meyer KC. Silent gastro-oesophageal reflux and microaspiration in IPF: mounting evidence for anti-reflux therapy? Eur Respir J. 2012;39(2):242–245.
   PubMed Web of Science ®Google Scholar
• Franquet T, Giménez A, Rosón N, et al. Aspiration diseases: findings, pitfalls, and differential diagnosis. Radiographics. 2000;20(3):673–685.
   PubMed Web of Science ®Google Scholar
• Nemec SF, Bankier AA, Eisenberg RL. Lower lobe-predominant diseases of the lung. AJR Am J Roentgenol. 2013;200(4):712–728.
   PubMed Web of Science ®Google Scholar
• Savarino E, Carbone R, Marabotto E, et al. Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients. Eur Respir J. 2013;42(5):1322–1331.
   PubMed Web of Science ®Google Scholar
• Lee JS, Collard HR, Raghu G, et al. Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med. 2010;123(4):304–311.
   PubMed Web of Science ®Google Scholar
• Hou YJ, Okuda K, Edwards CE, et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. 2020;182(2):429–446 e14.
   PubMed Web of Science ®Google Scholar
• Nguyen TL, Perlman CE. Tracheal acid or surfactant instillation raises alveolar surface tension. J Appl Physiol. 2018;125(5):1357–1367. 1985.
   PubMed Web of Science ®Google Scholar
• Evans CM, Fingerlin TE, Schwarz MI, et al. Idiopathic pulmonary fibrosis: a genetic disease that involves mucociliary dysfunction of the peripheral airways. Physiol Rev. 2016;96(4):1567–1591.
   PubMed Web of Science ®Google Scholar
• Selman M, King TE, Pardo A, et al. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med. 2001;134(2):136–151.
   PubMed Web of Science ®Google Scholar
• Bringardner BD, Baran CP, Eubank TD, et al. The role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis. Antioxid Redox Signal. 2008;10(2):287–301.
   PubMed Web of Science ®Google Scholar
• Balestro E, Calabrese F, Turato G, et al. Immune inflammation and disease progression in idiopathic pulmonary fibrosis. PLoS One. 2016;11(5):e0154516.
   PubMed Web of Science ®Google Scholar
• Desai O, Winkler, J, Minasyan, M, et al. The role of immune and inflammatory cells in idiopathic pulmonary fibrosis. Front Med (Lausanne). 2018;5:43.
   PubMed Web of Science ®Google Scholar
• Lin C, Borensztajn K, Spek CA. Targeting coagulation factor receptors - protease-activated receptors in idiopathic pulmonary fibrosis. J Thromb Haemost. 2017;15(4):597–607.
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Yow E, Flaherty KR, et al. Effect of antimicrobial therapy on respiratory hospitalization or death in adults with idiopathic pulmonary fibrosis: the cleanUP-IPF randomized clinical trial. JAMA. 2021;325(18):1841–1851.
   PubMed Web of Science ®Google Scholar
• Plante-Bordeneuve T, Pilette C, Froidure A. The epithelial-immune crosstalk in pulmonary fibrosis. Vol. 12. Switzerland: Front Immunol; 2021. p. 631235.
   Google Scholar